Table of Content


Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Implantable medical devices industry 360 degree synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Type trends
2.1.4 Nature of device trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Implantable Medical Devices Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of chronic diseases across the globe
3.2.1.2 Scarcity of organ donors
3.2.1.3 Technological advancement in developed nations
3.2.1.4 Rising government funding for implantable medical devices in developed countries
3.2.1.5 Increasing focus on development of microelectronics and implantable sensors
3.2.1.6 Growing adoption of biomaterials for better biocompatibility and outcomes
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.2.2.2 Stringent regulations for active implantable medical devices
3.2.2.3 Considerable rate of post-procedural complications
3.2.2.4 High number of recalls of implantable medical devices
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By type
3.3.3 By nature of devices
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 Asia Pacific
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Pricing analysis, 2021
3.9 Trend in adoption of materials for manufacture of implantable medical devices
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Company market share analysis, 2021
Chapter 5 Implantable Medical Devices Market, By Product
5.1 Key segment trends
5.2 Cardiovascular
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Pacemaker
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Implantable cardiac defibrillators (ICDs)
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Cardiac Resynchronization Therapy (CRT)
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Stents
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.6 Ventricular assist devices
5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.7 Implantable cardiac monitors (ICM)
5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.8 Others
5.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Orthopedic
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Joint reconstruction
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Trauma fixation devices
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Spinal devices
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.5 Others
5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Ophthalmology
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Intraocular lenses & glaucoma implants
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Others
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Plastic surgery
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Breast implants
5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.3 Gluteal implants
5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Neurology
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Deep brain stimulators
5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.3 Others
5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7 Dental
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.2 Dental implants
5.7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.3 Dental crowns & abutment
5.7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.4 Others
5.7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.8 Others
5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Implantable Medical Devices Market, By Type
6.1 Key segment trends
6.2 Treatment
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Diagnostic
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Implantable Medical Devices Market, By Nature of Devices
7.1 Key segment trends
7.2 Active
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Static/Non-active/Passive
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Implantable Medical Devices Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Multi-specialty centers
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Ambulatory surgical centers
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Clinics
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.6 Others
8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Implantable Medical Devices Market Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Poland
9.3.7 Austria
9.3.8 Switzerland
9.3.9 Sweden
9.3.10 Denmark
9.3.11 Slovakia
9.3.12 Czech Republic
9.3.13 Finland
9.3.14 Benelux
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.4.7 Indonesia
9.4.8 Thailand
9.4.9 Vietnam
9.4.10 Cambodia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Medtronic Plc
10.2 Zimmer Biomet
10.3 AbbVie Inc. (Allergan plc)
10.4 MicroPort Scientific Corporation
10.5 Stryker Corporation
10.6 Smith & Nephew plc
10.7 Boston Scientific Corporation
10.8 Abbott Laboratories, Inc
10.9 Alcon Laboratories
10.10 Bausch & Lomb
10.11 Mindray Medical International Limited
10.12 POLYTECH Health & Aesthetics
10.13 MED-EL GmbH
10.14 Demant A/S
10.15 Advanced Bionics Corporation (Sonova Holdings AG)
10.16 Cochlear Limited
10.17 W. L. Gore & Associates, Inc
10.18 Johnson & Johnson
10.19 Henry Schein, Inc
10.20 BIOTRONIK SE & Co. KG